S&P 500   4,446.41 (-0.20%)
DOW   34,941.26 (+0.41%)
QQQ   369.60 (-1.00%)
AAPL   145.11 (-1.23%)
MSFT   293.82 (-1.85%)
FB   351.55 (-0.40%)
GOOGL   2,823.03 (-0.75%)
TSLA   793.70 (+2.49%)
AMZN   3,378.63 (-1.37%)
NVDA   214.93 (-2.66%)
BABA   148.12 (+2.10%)
NIO   36.37 (+2.80%)
CGC   14.72 (+5.82%)
GE   105.94 (+2.06%)
MU   75.15 (+1.49%)
AMD   107.32 (+1.44%)
T   27.61 (+1.77%)
F   14.26 (+3.48%)
ACB   6.39 (+7.39%)
DIS   178.86 (+1.63%)
PFE   43.76 (-0.41%)
BA   226.01 (+2.09%)
BAC   43.34 (+2.85%)
S&P 500   4,446.41 (-0.20%)
DOW   34,941.26 (+0.41%)
QQQ   369.60 (-1.00%)
AAPL   145.11 (-1.23%)
MSFT   293.82 (-1.85%)
FB   351.55 (-0.40%)
GOOGL   2,823.03 (-0.75%)
TSLA   793.70 (+2.49%)
AMZN   3,378.63 (-1.37%)
NVDA   214.93 (-2.66%)
BABA   148.12 (+2.10%)
NIO   36.37 (+2.80%)
CGC   14.72 (+5.82%)
GE   105.94 (+2.06%)
MU   75.15 (+1.49%)
AMD   107.32 (+1.44%)
T   27.61 (+1.77%)
F   14.26 (+3.48%)
ACB   6.39 (+7.39%)
DIS   178.86 (+1.63%)
PFE   43.76 (-0.41%)
BA   226.01 (+2.09%)
BAC   43.34 (+2.85%)
S&P 500   4,446.41 (-0.20%)
DOW   34,941.26 (+0.41%)
QQQ   369.60 (-1.00%)
AAPL   145.11 (-1.23%)
MSFT   293.82 (-1.85%)
FB   351.55 (-0.40%)
GOOGL   2,823.03 (-0.75%)
TSLA   793.70 (+2.49%)
AMZN   3,378.63 (-1.37%)
NVDA   214.93 (-2.66%)
BABA   148.12 (+2.10%)
NIO   36.37 (+2.80%)
CGC   14.72 (+5.82%)
GE   105.94 (+2.06%)
MU   75.15 (+1.49%)
AMD   107.32 (+1.44%)
T   27.61 (+1.77%)
F   14.26 (+3.48%)
ACB   6.39 (+7.39%)
DIS   178.86 (+1.63%)
PFE   43.76 (-0.41%)
BA   226.01 (+2.09%)
BAC   43.34 (+2.85%)
S&P 500   4,446.41 (-0.20%)
DOW   34,941.26 (+0.41%)
QQQ   369.60 (-1.00%)
AAPL   145.11 (-1.23%)
MSFT   293.82 (-1.85%)
FB   351.55 (-0.40%)
GOOGL   2,823.03 (-0.75%)
TSLA   793.70 (+2.49%)
AMZN   3,378.63 (-1.37%)
NVDA   214.93 (-2.66%)
BABA   148.12 (+2.10%)
NIO   36.37 (+2.80%)
CGC   14.72 (+5.82%)
GE   105.94 (+2.06%)
MU   75.15 (+1.49%)
AMD   107.32 (+1.44%)
T   27.61 (+1.77%)
F   14.26 (+3.48%)
ACB   6.39 (+7.39%)
DIS   178.86 (+1.63%)
PFE   43.76 (-0.41%)
BA   226.01 (+2.09%)
BAC   43.34 (+2.85%)
NYSE:IMAX

IMAX Stock Forecast, Price & News

$18.42
+0.54 (+3.02 %)
(As of 09/27/2021 12:21 PM ET)
Add
Compare
Today's Range
$18.12
$18.54
50-Day Range
$13.67
$17.89
52-Week Range
$10.50
$25.05
Volume6,559 shs
Average Volume846,014 shs
Market Capitalization$1.09 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.77
30 days | 90 days | 365 days | Advanced Chart
Receive IMAX News and Ratings via Email

Sign-up to receive the latest news and ratings for IMAX and its competitors with MarketBeat's FREE daily newsletter.


IMAX logo

About IMAX

IMAX Corp. is an entertainment technology company, which engages in the business of motion picture technologies and presentations. It operates through following four business segments: IMAX Technology Network; IMAX Technology Sales and Maintenance; New Business Initiatives; and Film Distribution and Post-Production. The IMAX Technology Network segment represents box office results and which includes the reportable segment of IMAX DMR and contingent rent from the joint revenue sharing arrangements and IMAX systems segments. The IMAX Technology Sales and Maintenance segment includes the sale and installation of theater systems and maintenance services, primarily related to the IMAX Systems and Theater System Maintenance. The New Business Initiatives segment involves content licensing and distribution fees associated with the firm's original content investments, virtual reality initiatives, IMAX Home Entertainment, and other business initiatives that are in the development and/or start-up phase. The Film Distribution and Post-Production segment provides licenses film content and distributes large-format films, primarily for its institutional theater partners. The company was founded

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

2.46 out of 5 stars

Consumer Discretionary Sector

76th out of 384 stocks

Photographic Equipment & Supplies Industry

1st out of 4 stocks

Analyst Opinion: 3.3Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











IMAX (NYSE:IMAX) Frequently Asked Questions

Is IMAX a buy right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for IMAX in the last year. There are currently 1 sell rating, 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" IMAX stock.
View analyst ratings for IMAX
or view top-rated stocks.

What stocks does MarketBeat like better than IMAX?

Wall Street analysts have given IMAX a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but IMAX wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is IMAX's next earnings date?

IMAX is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for IMAX
.

How were IMAX's earnings last quarter?

IMAX Co. (NYSE:IMAX) issued its quarterly earnings data on Monday, July, 26th. The company reported ($0.12) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.27) by $0.15. The firm had revenue of $50.96 million for the quarter, compared to the consensus estimate of $43.79 million. IMAX had a negative net margin of 50.56% and a negative trailing twelve-month return on equity of 22.38%. The company's revenue was up 475.4% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.44) EPS.
View IMAX's earnings history
.

How has IMAX's stock been impacted by COVID-19?

IMAX's stock was trading at $14.61 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, IMAX stock has increased by 25.9% and is now trading at $18.40.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for IMAX?

9 brokers have issued twelve-month price objectives for IMAX's shares. Their forecasts range from $18.60 to $30.00. On average, they expect IMAX's share price to reach $24.07 in the next twelve months. This suggests a possible upside of 30.8% from the stock's current price.
View analysts' price targets for IMAX
or view top-rated stocks among Wall Street analysts.

Who are IMAX's key executives?

IMAX's management team includes the following people:
  • Richard Lewis Gelfond, Chief Executive Officer & Director
  • Joseph Sparacio, Chief Financial Officer
  • Pablo Calamera, Chief Technology Officer & Executive VP
  • Robert D. Lister, Chief Legal Officer & Senior Executive VP
  • Megan Colligan, Executive Vice President

What is Richard L. Gelfond's approval rating as IMAX's CEO?

36 employees have rated IMAX CEO Richard L. Gelfond on Glassdoor.com. Richard L. Gelfond has an approval rating of 63% among IMAX's employees. This puts Richard L. Gelfond in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of IMAX's key competitors?

What other stocks do shareholders of IMAX own?

What is IMAX's stock symbol?

IMAX trades on the New York Stock Exchange (NYSE) under the ticker symbol "IMAX."

Who are IMAX's major shareholders?

IMAX's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (5.16%), Invesco Ltd. (4.45%), Alliancebernstein L.P. (4.13%), Renaissance Technologies LLC (3.25%), FMR LLC (3.13%) and Dimensional Fund Advisors LP (2.49%). Company insiders that own IMAX stock include Denny Tu, Giovanni M Dolci, Jacqueline Bassani, Jeffrey Vance, Kenneth Ian Weissman, Mark Welton, Megan Colligan, Patrick Mcclymont, Richard L Gelfond and Robert D Lister.
View institutional ownership trends for IMAX
.

Which major investors are selling IMAX stock?

IMAX stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Schonfeld Strategic Advisors LLC, Primecap Management Co. CA, Massachusetts Financial Services Co. MA, Peconic Partners LLC, Dimensional Fund Advisors LP, Franklin Resources Inc., and Nuveen Asset Management LLC. Company insiders that have sold IMAX company stock in the last year include Denny Tu, Jacqueline Bassani, Kenneth Ian Weissman, Mark Welton, and Megan Colligan.
View insider buying and selling activity for IMAX
or view top insider-selling stocks.

Which major investors are buying IMAX stock?

IMAX stock was bought by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Goldman Sachs Group Inc., Lord Abbett & CO. LLC, Wells Fargo & Company MN, Connors Investor Services Inc., Balyasny Asset Management LLC, Bank of New York Mellon Corp, and Deutsche Bank AG. Company insiders that have bought IMAX stock in the last two years include Richard L Gelfond, and Robert D Lister.
View insider buying and selling activity for IMAX
or or view top insider-buying stocks.

How do I buy shares of IMAX?

Shares of IMAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is IMAX's stock price today?

One share of IMAX stock can currently be purchased for approximately $18.40.

How much money does IMAX make?

IMAX has a market capitalization of $1.09 billion and generates $137 million in revenue each year. The company earns $-143,770,000.00 in net income (profit) each year or ($2.23) on an earnings per share basis.

How many employees does IMAX have?

IMAX employs 622 workers across the globe.

What is IMAX's official website?

The official website for IMAX is www.imax.com.

Where are IMAX's headquarters?

How can I contact IMAX?

IMAX's mailing address is 2525 Speakman Drive, Mississauga A6, L5K 1B1. The company can be reached via phone at (905) 403-6500 or via email at [email protected].


This page was last updated on 9/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.